Switzerland’s BB Biotech shares surged the most in over two years, following news that billionaire Paul Singer increased his stake in the fund to 5.47%. In November of last year, Singer disclosed that his firm owned 3.1% of BB Biotech shares. Singer ups stake in BB Biotech BB Biotech AG is a Swiss health-industry investment fund. Paul Singer, who runs hedge-fund firm Elliot Management, enhanced his stake in the Kuesnacht, Switzerland-based company to 5.47% as of December 23, up from 3.11% previously, according to a filing at Swiss Six Exchange. In the filing, it was disclosed that: “Pursuant to Art….
On This Page
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
